Key facts
- Max Hodak, founder of Science Corporation and co-founder of Neuralink, will speak at TechCrunch Disrupt 2026.
- Hodak will advocate for brain-computer interfaces as the next technological paradigm, moving beyond screens.
- Science Corporation's PRIMA implant has successfully restored vision in individuals with severe vision loss.
- Science Corporation secured $230 million in Series C funding at a $1.5 billion valuation.
- The company is investigating brain-implanted sensors for applications in cognition, mobility, and treating conditions like Parkinson's disease.
Max Hodak, founder of Science Corporation and co-founder of Neuralink, is scheduled to speak at TechCrunch Disrupt 2026, where he plans to outline his vision for a future beyond screen-based technology, driven by brain-computer interfaces (BCIs). Hodak, who has a background in biomedical engineering and worked in a BCI lab at Duke University, also co-founded Transcriptic, a robotic cloud laboratory. He established Science Corporation in 2021 to advance neural engineering and BCI technologies. The company's PRIMA implant has demonstrated success in restoring vision for individuals with severe sight loss by using a camera-equipped pair of glasses to transmit images to a chip implanted in the retina. Science Corporation has raised $230 million in a Series C funding round, achieving a valuation of $1.5 billion. Beyond vision restoration, Hodak envisions the company's implanted sensors aiding cognitive and mobility functions, and potentially treating neurological conditions such as Parkinson's disease and warning about seizures. TechCrunch Disrupt 2026 will take place at Moscone West in San Francisco from October 13-15, expecting over 10,000 founders, investors, and startup community members. The event will feature a significant focus on sustainable AI companies.